This company has been marked as potentially delisted and may not be actively trading. Interpace Biosciences (IDXG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock IDXG vs. LH, DGX, DVA, CHE, CRVL, MD, AMN, CCRN, BTCY, and IVFShould you be buying Interpace Biosciences stock or one of its competitors? The main competitors of Interpace Biosciences include Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Biotricity (BTCY), and INVO Fertility (IVF). Interpace Biosciences vs. Its Competitors Labcorp Quest Diagnostics DaVita Chemed CorVel Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Biotricity INVO Fertility Labcorp (NYSE:LH) and Interpace Biosciences (NASDAQ:IDXG) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment. Which has more volatility and risk, LH or IDXG? Labcorp has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, Interpace Biosciences has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500. Is LH or IDXG more profitable? Interpace Biosciences has a net margin of 10.39% compared to Labcorp's net margin of 5.66%. Labcorp's return on equity of 15.45% beat Interpace Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Labcorp5.66% 15.45% 7.02% Interpace Biosciences 10.39%-8.09%37.14% Which has stronger valuation & earnings, LH or IDXG? Labcorp has higher revenue and earnings than Interpace Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLabcorp$13.01B1.78$746M$9.0630.68Interpace Biosciences$40.21M0.11$800KN/AN/A Does the media favor LH or IDXG? In the previous week, Labcorp had 21 more articles in the media than Interpace Biosciences. MarketBeat recorded 22 mentions for Labcorp and 1 mentions for Interpace Biosciences. Labcorp's average media sentiment score of 0.86 beat Interpace Biosciences' score of 0.00 indicating that Labcorp is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 8 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Interpace Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend LH or IDXG? Labcorp currently has a consensus target price of $292.00, indicating a potential upside of 5.05%. Given Labcorp's stronger consensus rating and higher probable upside, analysts plainly believe Labcorp is more favorable than Interpace Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 0 Sell rating(s) 4 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.71Interpace Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders believe in LH or IDXG? 95.9% of Labcorp shares are held by institutional investors. Comparatively, 5.7% of Interpace Biosciences shares are held by institutional investors. 0.8% of Labcorp shares are held by company insiders. Comparatively, 5.5% of Interpace Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryLabcorp beats Interpace Biosciences on 11 of the 14 factors compared between the two stocks. Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDXG vs. The Competition Export to ExcelMetricInterpace BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.31M$75.93M$6.10B$10.63BDividend YieldN/AN/A5.67%4.71%P/E RatioN/A9.8685.2726.57Price / Sales0.1142.68612.78132.63Price / Cash1.9918.4138.5062.09Price / Book-0.0715.9112.726.53Net Income$800K-$27.29M$3.30B$275.96M Interpace Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDXGInterpace BiosciencesN/A$0.98+5.0%N/A-54.6%$4.31M$40.21M0.00152LHLabcorp4.7518 of 5 stars$279.40+1.6%$292.00+4.5%+29.3%$22.86B$13.01B30.8470,000Trending NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionDGXQuest Diagnostics4.7215 of 5 stars$181.95+2.0%$186.31+2.4%+24.7%$19.95B$9.87B21.7956,000Positive NewsAnalyst ForecastAnalyst RevisionDVADaVita4.7598 of 5 stars$131.09+2.3%$158.00+20.5%-22.3%$9.16B$12.82B12.8976,000News CoverageAnalyst ForecastCHEChemed4.9986 of 5 stars$435.93+0.1%$578.50+32.7%-27.2%$6.34B$2.43B22.4115,695Analyst ForecastCRVLCorVel1.2649 of 5 stars$74.11-0.7%N/A-29.0%$3.83B$895.59M38.205,075MDPediatrix Medical Group1.8558 of 5 stars$17.65+0.0%$16.79-4.9%+31.6%$1.54B$2.01B13.684,305News CoverageAnalyst DowngradeAnalyst RevisionAMNAMN Healthcare Services4.4515 of 5 stars$19.40-2.0%$23.25+19.8%-52.9%$758.44M$2.98B-2.502,968Analyst ForecastCCRNCross Country Healthcare3.569 of 5 stars$13.12-1.4%$17.93+36.7%-4.8%$435.73M$1.34B-50.468,205News CoverageAnalyst ForecastBTCYBiotricityN/A$0.48-2.1%N/A+127.3%$12.83M$12.06M-0.4440Gap UpIVFINVO Fertility0.5521 of 5 stars$0.76-4.1%N/A-97.0%$3.47M$6.53M-0.0110News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies Labcorp Competitors Quest Diagnostics Competitors DaVita Competitors Chemed Competitors CorVel Competitors Pediatrix Medical Group Competitors AMN Healthcare Services Competitors Cross Country Healthcare Competitors Biotricity Competitors INVO Fertility Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDXG) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interpace Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interpace Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
